https://ordaos.bio/press/2022/12/19/orda%C5%8Ds-announces-a-joint-development-agreement-to-create-novel-therapeutics-for-amlhttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/footer-logo.svgfooterlogofooterlogohttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image.webpimageimage2025-04-02https://ordaos.bio/press/2023/08/17/orda%C5%8Ds-uses-ai-to-generate-therapeutic-mini-proteinshttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/footer-logo.svgfooterlogofooterlogohttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image.webpimageimage2025-04-02https://ordaos.bio/press/2023/06/09/orda%C5%8Ds-selected-to-participate-in-the-aws-generative-ai-acceleratorhttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image.webpimageimagehttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/footer-logo.svgfooterlogofooterlogo2025-04-02https://ordaos.bio/press/2023/08/18/chatgpt-is-just-the-tip-of-the-iceberg-in-content-creating-artificial-intelligence-get-ready-for-a-lot-of-disruptionhttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Imported_Blog_Media/Stock-ChatGPT-01-shutt.jpgStockChatGPT01shuttStockChatGPT01shutthttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/footer-logo.svgfooterlogofooterlogohttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Imported_Blog_Media/wA1chatGPT020623.jpgwA1chatGPT020623wA1chatGPT020623https://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Imported_Blog_Media/Stock-SambaNova-datascale-01-company.jpgStockSambaNovadatascale01companyStockSambaNovadatascale01companyhttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image.webpimageimagehttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Imported_Blog_Media/Stock-Neevasystems-01-shutt.jpgStockNeevasystems01shuttStockNeevasystems01shutthttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Imported_Blog_Media/Stock-OpenAI-01-shutt.jpgStockOpenAI01shuttStockOpenAI01shutthttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Imported_Blog_Media/wChatGPT020223.jpgwChatGPT020223wChatGPT020223https://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Imported_Blog_Media/A7JUMP_bots_inline_020323_newscom.jpgA7JUMPbotsinline020323newscomA7JUMPbotsinline020323newscomhttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Imported_Blog_Media/Stock-WaymoVan-02-company.jpgStockWaymoVan02companyStockWaymoVan02company2025-04-02https://ordaos.bio/privacy-policyhttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image.webpimageimagehttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/hero-gyro.svgherogyroherogyrohttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/footer-logo.svgfooterlogofooterlogo2025-04-14https://ordaos.bio/press/2022/10/12/orda%C5%8Ds-nonexomics-deal-shines-light-on-novel-mini-proteinshttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/footer-logo.svgfooterlogofooterlogohttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image.webpimageimage2025-04-02https://ordaos.bio/press/2023/02/22/orda%C5%8Ds-and-fatiabgen-partner-to-optimize-therapeutics-for-challenging-oncology-conditionshttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/footer-logo.svgfooterlogofooterlogohttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image.webpimageimage2025-04-02https://ordaos.bio/press/2023/08/24/orda%C5%8Ds-opens-lab-space-in-jlabs-nychttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image.webpimageimagehttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/footer-logo.svgfooterlogofooterlogo2025-04-02https://ordaos.bio/press/2023/02/01/the-generative-ai-revolution-is-creating-the-next-phase-of-autonomous-enterprisehttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/footer-logo.svgfooterlogofooterlogohttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image.webpimageimage2025-04-02https://ordaos.bio/press/2021/07/22/vyant-bio-inc-orda%C5%8Ds-bio-and-cellaria-inc-announce-collaboration-to-design-and-qualify-biomarker-specific-small-protein-therapeuticshttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/footer-logo.svgfooterlogofooterlogohttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image.webpimageimage2025-04-02https://ordaos.bio/press/2022/10/12/orda%C5%8Ds-and-nonexomics-announce-research-collaborationhttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image.webpimageimagehttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/footer-logo.svgfooterlogofooterlogo2025-04-02https://ordaos.bio/case-studies/deep-learning-based-protein-therapeutics-design-to-treat-her2-cancershttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image.webpimageimagehttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/footer-logo.svgfooterlogofooterlogohttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/results.webpresultsresults2025-04-14https://ordaos.bio/case-studies/using-deep-learning-to-discover-functional-antibodies-for-sars-cov-2-with-picomolar-binding-affinityhttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image.webpimageimagehttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/footer-logo.svgfooterlogofooterlogohttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/pegs.webppegspegs2025-04-14https://ordaos.bio/press/2023/08/24/scrip-asks-what-does-2023-hold-for-biopharma-part-6-artificial-intelligencehttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image.webpimageimagehttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/footer-logo.svgfooterlogofooterlogo2025-04-02https://ordaos.bio/press/2022/10/12/mini-proteins-combine-best-of-monoclonals-and-small-molecule-drugshttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image.webpimageimagehttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/footer-logo.svgfooterlogofooterlogo2025-04-02https://ordaos.bio/contact-ushttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/footer-logo.svgfooterlogofooterlogohttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image.webpimageimage2025-04-10https://ordaos.bio/eventshttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/footer-logo.svgfooterlogofooterlogohttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image.webpimageimage2026-03-08https://ordaos.bio/press/2022/12/15/orda%C5%8Ds-announces-appointment-of-ziwei-liang-phd-to-role-of-chief-science-officerhttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/footer-logo.svgfooterlogofooterlogohttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image.webpimageimage2025-04-02https://ordaos.biohttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image.webpimageimagehttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image%20(4).webpimage4image4https://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/screenshot-2024-02-15-at-2.03.49%20pm.pngscreenshot20240215at20349pmscreenshot20240215at20349pmhttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image%20(22).webpimage22image22https://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image%20(3).webpimage3image3https://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image%20(17).webpimage17image17https://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image%20(13).webpimage13image13https://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/tw-col-1.webptwcol1twcol1https://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/home-hero.svghomeherohomeherohttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image%20(10).webpimage10image10https://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image%20(20).webpimage20image20https://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image%20(2).webpimage2image2https://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image%20(11).webpimage11image11https://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image%20(19).webpimage19image19https://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image%20(1).webpimage1image1https://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image%20(8).webpimage8image8https://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image%20(16).webpimage16image16https://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image%20(15).webpimage15image15https://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image%20(6).webpimage6image6https://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image%20(5).webpimage5image5https://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image-1.webpimage1image1https://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/screenshot-2024-02-15-at-2.01.58%20pm.pngscreenshot20240215at20158pmscreenshot20240215at20158pmhttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Slide1-1.jpgSlide11Slide11https://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image%20(7).webpimage7image7https://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image%20(18).webpimage18image18https://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/footer-logo.svgfooterlogofooterlogohttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image%20(9).webpimage9image9https://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image%20(14).webpimage14image14https://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image%20(21).webpimage21image21https://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/screenshot-2024-02-15-at-2.00.47%20pm.pngscreenshot20240215at20047pmscreenshot20240215at20047pm2026-01-09https://ordaos.bio/press/2023/03/09/can-drug-design-replace-drug-discovery-current-jlabs-resident-ordaos-thinks-so-and-explains-howhttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/footer-logo.svgfooterlogofooterlogohttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image.webpimageimage2025-04-02https://ordaos.bio/press/2022/08/25/orda%C5%8Ds-raises-5-million-in-seed-to-accelerate-drug-design-and-discoveryhttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image.webpimageimagehttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/footer-logo.svgfooterlogofooterlogo2025-04-02https://ordaos.bio/press/2023/08/24/orda%C3%B5s-looks-to-unlock-the-therapeutic-promise-of-mini-proteinshttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/footer-logo.svgfooterlogofooterlogohttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image.webpimageimage2025-04-02https://ordaos.bio/teamhttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image%20(1)-1.webpimage11image11https://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image%20(16)-1.webpimage161image161https://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Howard-dark-background.jpegHowarddarkbackgroundHowarddarkbackgroundhttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image-2.webpimage2image2https://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Sasen_Gray.jpgSasenGraySasenGrayhttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Max.jpegMaxMaxhttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Jonas.jpgJonasJonashttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/footer-logo.svgfooterlogofooterlogohttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Shane.jpegShaneShanehttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Luke.jpegLukeLukehttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image%20(2)-1.webpimage21image21https://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Daniel.jpgDanielDanielhttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Jasmine.jpegJasmineJasminehttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/John.jpgJohnJohnhttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ilya.jpegIlyaIlyahttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Matthias.jpegMatthiasMatthiashttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Victor.jpgVictorVictorhttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Alena.jpegAlenaAlenahttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image.webpimageimagehttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Sahil.jpgSahilSahilhttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Jeff-1.jpegJeff1Jeff1https://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Dave%20headshot-1-1.jpegDaveheadshot11Daveheadshot11https://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/houssem.jpghoussemhoussemhttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Alexandru.jpegAlexandruAlexandruhttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Lahari-1.jpegLahari1Lahari1https://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image%20(18)-1.webpimage181image181https://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Steve.jpgSteveSteve2025-12-12https://ordaos.bio/press/2023/06/30/ai-has-secured-a-footing-in-drug-discovery-where-does-it-go-from-herehttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/footer-logo.svgfooterlogofooterlogohttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image.webpimageimage2025-04-02https://ordaos.bio/presshttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image.webpimageimagehttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/screenshot-2024-02-15-at-2.00.47%20pm.pngscreenshot20240215at20047pmscreenshot20240215at20047pmhttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/screenshot-2024-02-15-at-2.01.58%20pm.pngscreenshot20240215at20158pmscreenshot20240215at20158pmhttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/footer-logo.svgfooterlogofooterlogohttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/screenshot-2024-02-15-at-2.03.49%20pm.pngscreenshot20240215at20349pmscreenshot20240215at20349pm2025-04-08https://ordaos.bio/press/2025/03/12/quercus-biosolutions-emerges-from-stealth-to-disrupt-crop-protection-with-designer-mini-proteinshttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/footer-logo.svgfooterlogofooterlogohttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image.webpimageimage2025-04-08https://ordaos.bio/case-studies/update-using-deep-learning-to-discover-functional-antibodies-for-sars-cov-2-with-picomolar-binding-affinityhttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/footer-logo.svgfooterlogofooterlogohttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/image%20-aet.webpimageaetimageaethttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image.webpimageimage2025-04-14https://ordaos.bio/terms-of-usehttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/footer-logo.svgfooterlogofooterlogohttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/hero-gyro.svgherogyroherogyrohttps://7040627.fs1.hubspotusercontent-na1.net/hubfs/7040627/Ordaos_April2025/images/image.webpimageimage2025-04-09